Clinical Trial Update: Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery Disease [NA]

View source ↗

Summary

A clinical trial is evaluating a hybrid PCI strategy using a bioresorbable scaffold and drug-coated balloons against a conventional drug-eluting stent approach …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Diffuse Coronary Artery Disease

Snippet

Sponsor: University Hospital, Geneva | Conditions: Coronary Artery Disease, Diffuse Coronary Artery Disease | NA | Status: NOT_YET_RECRUITING